Impact of Renal Impairment on Intensive Blood-Pressure–Lowering Therapy and Outcomes in Intracerebral Hemorrhage

  • Mayumi Fukuda-Doi
    From the Departments of Cerebrovascular Medicine (M.F.-D., M.K., S.Y., K.M., A.I., M.S., K.T.), Data Science (M.F.-D., H.Y., K.O.), and Neurology (M.I.), National Cerebral and Cardiovascular Center; Department of Nephrology (Y.D.), Osaka University Graduate School of Medicine, Suita, Japan; Zeenat Qureshi Stroke Institute (A.I.Q.), St. Cloud, MN; and Department of Neurology (A.I.Q.), University of Missouri, Columbia.
  • Haruko Yamamoto
    From the Departments of Cerebrovascular Medicine (M.F.-D., M.K., S.Y., K.M., A.I., M.S., K.T.), Data Science (M.F.-D., H.Y., K.O.), and Neurology (M.I.), National Cerebral and Cardiovascular Center; Department of Nephrology (Y.D.), Osaka University Graduate School of Medicine, Suita, Japan; Zeenat Qureshi Stroke Institute (A.I.Q.), St. Cloud, MN; and Department of Neurology (A.I.Q.), University of Missouri, Columbia.
  • Masatoshi Koga
    From the Departments of Cerebrovascular Medicine (M.F.-D., M.K., S.Y., K.M., A.I., M.S., K.T.), Data Science (M.F.-D., H.Y., K.O.), and Neurology (M.I.), National Cerebral and Cardiovascular Center; Department of Nephrology (Y.D.), Osaka University Graduate School of Medicine, Suita, Japan; Zeenat Qureshi Stroke Institute (A.I.Q.), St. Cloud, MN; and Department of Neurology (A.I.Q.), University of Missouri, Columbia.
  • Yohei Doi
    From the Departments of Cerebrovascular Medicine (M.F.-D., M.K., S.Y., K.M., A.I., M.S., K.T.), Data Science (M.F.-D., H.Y., K.O.), and Neurology (M.I.), National Cerebral and Cardiovascular Center; Department of Nephrology (Y.D.), Osaka University Graduate School of Medicine, Suita, Japan; Zeenat Qureshi Stroke Institute (A.I.Q.), St. Cloud, MN; and Department of Neurology (A.I.Q.), University of Missouri, Columbia.
  • Adnan I. Qureshi
    From the Departments of Cerebrovascular Medicine (M.F.-D., M.K., S.Y., K.M., A.I., M.S., K.T.), Data Science (M.F.-D., H.Y., K.O.), and Neurology (M.I.), National Cerebral and Cardiovascular Center; Department of Nephrology (Y.D.), Osaka University Graduate School of Medicine, Suita, Japan; Zeenat Qureshi Stroke Institute (A.I.Q.), St. Cloud, MN; and Department of Neurology (A.I.Q.), University of Missouri, Columbia.
  • Sohei Yoshimura
    From the Departments of Cerebrovascular Medicine (M.F.-D., M.K., S.Y., K.M., A.I., M.S., K.T.), Data Science (M.F.-D., H.Y., K.O.), and Neurology (M.I.), National Cerebral and Cardiovascular Center; Department of Nephrology (Y.D.), Osaka University Graduate School of Medicine, Suita, Japan; Zeenat Qureshi Stroke Institute (A.I.Q.), St. Cloud, MN; and Department of Neurology (A.I.Q.), University of Missouri, Columbia.
  • Kaori Miwa
    From the Departments of Cerebrovascular Medicine (M.F.-D., M.K., S.Y., K.M., A.I., M.S., K.T.), Data Science (M.F.-D., H.Y., K.O.), and Neurology (M.I.), National Cerebral and Cardiovascular Center; Department of Nephrology (Y.D.), Osaka University Graduate School of Medicine, Suita, Japan; Zeenat Qureshi Stroke Institute (A.I.Q.), St. Cloud, MN; and Department of Neurology (A.I.Q.), University of Missouri, Columbia.
  • Akiko Ishigami
    From the Departments of Cerebrovascular Medicine (M.F.-D., M.K., S.Y., K.M., A.I., M.S., K.T.), Data Science (M.F.-D., H.Y., K.O.), and Neurology (M.I.), National Cerebral and Cardiovascular Center; Department of Nephrology (Y.D.), Osaka University Graduate School of Medicine, Suita, Japan; Zeenat Qureshi Stroke Institute (A.I.Q.), St. Cloud, MN; and Department of Neurology (A.I.Q.), University of Missouri, Columbia.
  • Masayuki Shiozawa
    From the Departments of Cerebrovascular Medicine (M.F.-D., M.K., S.Y., K.M., A.I., M.S., K.T.), Data Science (M.F.-D., H.Y., K.O.), and Neurology (M.I.), National Cerebral and Cardiovascular Center; Department of Nephrology (Y.D.), Osaka University Graduate School of Medicine, Suita, Japan; Zeenat Qureshi Stroke Institute (A.I.Q.), St. Cloud, MN; and Department of Neurology (A.I.Q.), University of Missouri, Columbia.
  • Katsuhiro Omae
    From the Departments of Cerebrovascular Medicine (M.F.-D., M.K., S.Y., K.M., A.I., M.S., K.T.), Data Science (M.F.-D., H.Y., K.O.), and Neurology (M.I.), National Cerebral and Cardiovascular Center; Department of Nephrology (Y.D.), Osaka University Graduate School of Medicine, Suita, Japan; Zeenat Qureshi Stroke Institute (A.I.Q.), St. Cloud, MN; and Department of Neurology (A.I.Q.), University of Missouri, Columbia.
  • Masafumi Ihara
    From the Departments of Cerebrovascular Medicine (M.F.-D., M.K., S.Y., K.M., A.I., M.S., K.T.), Data Science (M.F.-D., H.Y., K.O.), and Neurology (M.I.), National Cerebral and Cardiovascular Center; Department of Nephrology (Y.D.), Osaka University Graduate School of Medicine, Suita, Japan; Zeenat Qureshi Stroke Institute (A.I.Q.), St. Cloud, MN; and Department of Neurology (A.I.Q.), University of Missouri, Columbia.
  • Kazunori Toyoda
    From the Departments of Cerebrovascular Medicine (M.F.-D., M.K., S.Y., K.M., A.I., M.S., K.T.), Data Science (M.F.-D., H.Y., K.O.), and Neurology (M.I.), National Cerebral and Cardiovascular Center; Department of Nephrology (Y.D.), Osaka University Graduate School of Medicine, Suita, Japan; Zeenat Qureshi Stroke Institute (A.I.Q.), St. Cloud, MN; and Department of Neurology (A.I.Q.), University of Missouri, Columbia.

書誌事項

タイトル別名
  • Results From ATACH-2

収録刊行物

  • Neurology

    Neurology 97 (9), e913-, 2021-08-31

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (2)*注記

もっと見る

参考文献 (34)*注記

もっと見る

関連プロジェクト

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ